KLP Kapitalforvaltning AS acquired a new position in shares of Globe Life Inc. (NYSE:GL – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 23,000 shares of the company’s stock, valued at approximately $2,565,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Hillsdale Investment Management Inc. bought a new stake in Globe Life in the 4th quarter valued at $820,000. Sei Investments Co. lifted its holdings in shares of Globe Life by 1.0% during the fourth quarter. Sei Investments Co. now owns 21,248 shares of the company’s stock worth $2,370,000 after buying an additional 206 shares in the last quarter. American Century Companies Inc. boosted its position in shares of Globe Life by 33.2% in the fourth quarter. American Century Companies Inc. now owns 144,815 shares of the company’s stock valued at $16,150,000 after acquiring an additional 36,113 shares during the period. Quantbot Technologies LP grew its stake in shares of Globe Life by 115.4% in the fourth quarter. Quantbot Technologies LP now owns 19,809 shares of the company’s stock valued at $2,209,000 after acquiring an additional 10,611 shares in the last quarter. Finally, Lee Danner & Bass Inc. bought a new position in Globe Life during the fourth quarter worth about $70,000. Institutional investors and hedge funds own 81.61% of the company’s stock.
Insider Buying and Selling at Globe Life
In other Globe Life news, CEO Frank M. Svoboda sold 11,000 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $122.31, for a total value of $1,345,410.00. Following the completion of the transaction, the chief executive officer now directly owns 18,948 shares in the company, valued at approximately $2,317,529.88. This represents a 36.73 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CMO Jennifer Allison Haworth sold 9,000 shares of Globe Life stock in a transaction on Monday, January 6th. The stock was sold at an average price of $112.91, for a total transaction of $1,016,190.00. Following the transaction, the chief marketing officer now owns 13,485 shares in the company, valued at approximately $1,522,591.35. This trade represents a 40.03 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 61,338 shares of company stock worth $7,239,630. 1.51% of the stock is currently owned by insiders.
Globe Life Trading Up 0.5 %
Globe Life (NYSE:GL – Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. Equities research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.
Globe Life Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Thursday, April 3rd will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date of this dividend is Thursday, April 3rd. This is a boost from Globe Life’s previous quarterly dividend of $0.24. Globe Life’s dividend payout ratio is presently 9.04%.
Analyst Ratings Changes
A number of research firms have issued reports on GL. Evercore ISI raised shares of Globe Life from an “in-line” rating to an “outperform” rating and boosted their price objective for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. Jefferies Financial Group boosted their price target on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a research note on Tuesday, December 10th. Keefe, Bruyette & Woods raised their price objective on Globe Life from $137.00 to $145.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 12th. Wells Fargo & Company upped their target price on Globe Life from $126.00 to $141.00 and gave the company an “overweight” rating in a research report on Wednesday, February 19th. Finally, BMO Capital Markets assumed coverage on Globe Life in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $114.00 price target on the stock. Five analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $135.60.
About Globe Life
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Further Reading
- Five stocks we like better than Globe Life
- Options Trading – Understanding Strike Price
- Energy Transfer: Powering Data With Dividends and Diversification
- What Is WallStreetBets and What Stocks Are They Targeting?
- Qualcomm Stock Is Coiling for a Breakout
- EV Stocks and How to Profit from Them
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.